BrewDog has commissioned a £12 million green gas plant that will power the production of over 176 million pints of beer each year, which would result in 7,500 fewer tons of carbon emissions annually when the facility in Ellon, Aberdeenshire, is running at full capacity.
The company will combine wastewater with spent yeast and hops from its brewing process at the plant, which will be 'digested' by bacteria and converted to biomethane. BrewDog intends to carbonate its beer with CO2 produced by the digester in the coming years.
The anaerobic digester will allow the craft beer maker to recycle the majority of the 200 million liters of wastewater generated each year during the brewing process while also producing bio-methane to power the brewery's boilers.
Sarah Warman, BrewDog’s director of sustainability, commented that their ambition is to make their beer the most planet-friendly on Earth, and they’ve taken giant strides towards that goal with their new bio-energy plant.


Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Bank of Japan Faces Rate Uncertainty Amid Middle East Oil Shock
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Gold Prices Rise Amid Geopolitical Tensions and Safe Haven Demand
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
Ukraine minerals deal: the idea that natural resource extraction can build peace has been around for decades
As the Black Summer megafires neared, people rallied to save wildlife and domestic animals. But it came at a real cost
U.S. Stock Futures Steady as Iran Reviews U.S. Ceasefire Proposal
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push 



